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the Netherlands Reference Laboratory for Bacterial Men-
ingitis. Standard methods for cost-effectiveness analysis
were used. Analysis was done from a societal perspective,
including direct and indirect costs of productivity loss
(friction-costs method; price levels in 1998 €; discount
rate of 4%). Cost-effectiveness ratios were expressed in
net costs per quality adjusted life year (QALY) gained.
Sensitivity analysis was performed on several key param-
eters of the model. RESULTS: In the base-case, through
vaccination 480 QALYs are gained, while total net costs
of the program are €5,546,923. The cost-effectiveness ra-
tio is €11,600 per QALY gained. Sensitivity analysis indi-
cates a cost-effectiveness range of €5,841 to 30,543 per
QALY gained. CONCLUSIONS: Vaccination of all new-
borns with meningococcal OMV vaccine has an accept-
able cost-effectiveness ratio compared to other interven-
tions in the Netherlands.
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OBJECTIVE:
 
 To provide a preliminary assessment of the
economic value of vaccinating 1-year old children against
varicella in Germany. METHODS: We developed a deci-
sion-analytic model to compare the clinical and economic
outcomes of a universal varicella vaccination program
versus no vaccination in infants. The model predicts the
clinical effects, direct and indirect costs, and the cost-effec-
tiveness of mass vaccination. Model input data were
mainly derived from a large survey conducted across Ger-
many and were complemented by literature data and ex-
pert estimates. In the survey, pediatricians, GP’s and
internists provided information extracted from 1334 ran-
domly selected varicella patient records. Epidemiological
data but also medical resource utilization such as physi-
cian consultations, medication, and hospitalization due
to disease complications was captured. Additionally,
work loss of caregivers and infected employed individu-
als was retrieved from the records. Since the survey was
completed only very recently, the analysis of the model
input data is preliminary. Valuation of the resources used
was done by applying unit costs obtained from official
medical tariff lists, drug compendiums, and other statis-
tics. Vaccine efficacy was assumed to be between 90%
and 97%, and vaccination coverage between 50% and
80%. Future costs were discounted at 5%. The perspec-
tive taken is that of the society. RESULTS: The prelimi-
nary findings presented here apply to a timeframe of 30
years. Over that period, the model predicts that universal
children vaccination could prevent between 7.4 and 11.2
million varicella infections, and between 53,000 and
88,000 major complications depending on the assump-
tions taken. Universal vaccination also appears to be eco-
nomically worthwhile with a benefit-cost ratio of be-
tween 2.1 and 1.9. CONCLUSIONS: These preliminary
results suggests that universal varicella vaccination pro-
vide significant clinical and economic benefits to the Ger-
man society. A final analysis is in process, which will be
an important information source for healthcare decision-
makers.
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OBJECTIVE
 
: To assess avoidable hospitalization as an
outcome indicator of access to and quality of primary
care by examining trends and gender and ethnic varia-
tions. METHOD: Aggregated nationwide data on annual
hospital discharges in Singapore from 1991 to 1998 were
collected from the Central Claims Processing System
(CCPS) database. They included total hospitalizations
(excluding maternity and psychiatric disorders) and hos-
pitalizations for chronic diseases, which are avoidable by
timely, appropriate and effective primary care (ambula-
tory care sensitive (ACS) conditions): asthma, congestive
heart failure, chronic obstructive pulmonary disease, dia-
betes mellitus and hypertension. Directly age-standard-
ized rates were adjusted for gender and ethnic differences
in total hospitalizations. RESULTS: From 1991 to 1998,
(total of 1,479,494 hospitalizations), 6.7% were for ACS
conditions. Overall, the annual rate of avoidable hospi-
talization was 29.4 per 10,000 population. Women had
lower rates of avoidable hospitalizations than males
(22.4 versus 29.5 per 10,000), as well as for total hospi-
talizations (496.2 versus 515.5 per 10,000). Adjusted for
total hospitalization, males were 1.3 times more likely
than females to be hospitalized for ACS conditions.
Compared to Chinese, Indian and Malays had higher
rates of avoidable hospitalizations (21.7, 65.5 and 56.1 per
10,000 respectively). Adjusting for their higher rates of
total hospitalization, they were 1.7 and 1.8 times respec-
tively more likely than Chinese to be admitted for ACS
conditions. Avoidable hospitalization decline (adjusted
for total hospitalization) was 9.1% overall; greater in
males (11.8%) than in females (5.3%); greater for
Chinese (15.8%), than Malays (1.1%) and Indians
(increase of 4.3%). Among Malays and Indians,
women showed marked increases of avoidable hospital-
izations, 10.8% and 8.1% respectively. CONCLU-
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SION:
 
 We demonstrated gender and ethnic differences
and temporal trends in avoidable hospitalization. Avoid-
able hospitalization is a sensitive tool for monitoring ac-
cess to and adequacy of primary ambulatory care.
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OBJECTIVE: A new method for measuring reduced pro-
ductivity during paid labor has been proposed in the
Health and Labor Questionnaire (HLQ). How this method
relates to the more common impairment approach is un-
known. Therefore, the objective of this study was to
compare the two methods of measurement. METHODS:
A face-to-face interview questionnaire with items on re-
duced productivity during paid labor was developed and
pilot-tested. The final interview was administered to a
convenience sample of 102 informal caregivers of the eld-
erly in an observational panel study with two survey
waves. Employed caregivers were asked to estimate the
extent to which their productivity while at work during
the previous two weeks was reduced by their caregiving
activities, using both the HLQ approach and an impair-
ment approach. In the HLQ approach, respondents esti-
mated the amount of time necessary to compensate for
their reduced productivity. In the impairment approach,
respondents rated their impairment on a scale from 0 to
10. Then, the impairment rating was converted to an
hourly value. Paired t-tests were conducted to examine
the differences between the HLQ approach and the im-
pairment approach. RESULTS: In the first survey wave,
53 employed caregivers reported an average of 9.0 hours
of reduced productivity using the impairment approach
compared to 3.5 hours using the HLQ approach. This
difference was statistically significant (P  0.01). In the
second survey wave, 54 employed caregivers reported an
average of 8.7 hours of reduced productivity using the
impairment approach compared to 4.0 hours using the
HLQ approach. Again, the difference was statistically
significant (P  0.01). CONCLUSIONS: The approach
used to measure reduced productivity during paid labor
influences the results obtained. Estimates of reduced pro-
ductivity during paid labor are greater when the impair-
ment measurement approach is used than when the HLQ
approach to measurement is used.
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OBJECTIVE: Measure the benefits of delaying the pro-
gression to blindness and compute an overall index that
summarizes the benefits to patients treated for eye prob-
lems. METHODS: Patient benefits are measured in terms
of the reduction in symptoms and disabilities, and in
terms of the patient’s ability to perform preferred activi-
ties in their daily living. The index is based on earlier
work in the field of index theory, distance functions, and
production economics. It uses both clinical outcome data
and data on specific daily life activities. The index results
in a single measure of relative changes in functional abil-
ity, for each individual. Daily life activities are treated as
outputs that the individual is able to perform. Resources
that the individual uses to achieve the outputs are treated
as inputs. Hence, treatment may increase the input level
of a particular individual and by that increase the output
possibility set, and subsequently the individual’s choice
between different output combinations. The situation be-
fore treatment is compared with the situation after treat-
ment. The index numbers are calculated from the Swed-
ish Cataract Register, and from clinical trial data. Cost
data are collected from the literature. RESULTS: The
suggested index approach successfully connects multidi-
mensional outcome data with daily life activities, without
being dependent on an a priori set of weights or second-
ary statistical analysis. The index allows different vari-
ables to be measured in different units without affecting
the resulting index number. The preliminary empirical re-
sults indicate that new technology and proper timing of
the medical intervention is crucial for the economic justi-
fication of the intervention. CONCLUSION: With a
minimum of assumptions the suggested index makes it
possible to analyze a medical intervention using all of the
appropriate variables. The index may prove particular
useful in the decision process of medical interventions
and when balancing costs and benefits.
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OBJECTIVE: To estimate the cost-effectiveness of
screening for LVSD in patients with cerebro-vascular ac-
cident (CVA), peripheral vascular disease (PVD) or tran-
sient ischaemic attack (TIA) versus age matched controls.
METHODS: Results of electrocardiography (ECG) or
measurement of brain natriuretic peptide (BNP) were
compared with echocardiography (LVSD  ejection frac-
